Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-133722
Filing Date
2021-11-03
Accepted
2021-11-03 17:01:21
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q syn-20210930x10q.htm   iXBRL 10-Q 1539030
2 EXHIBIT 31.1 syn-20210930xex31d1.htm EX-31.1 11525
3 EXHIBIT 32.1 syn-20210930xex32d1.htm EX-32.1 6280
4 GRAPHIC syn-20210930x10q001.jpg GRAPHIC 27654
  Complete submission text file 0001104659-21-133722.txt   5556711

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA syn-20210930.xsd EX-101.SCH 39639
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20210930_cal.xml EX-101.CAL 39888
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20210930_def.xml EX-101.DEF 171107
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20210930_lab.xml EX-101.LAB 292276
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20210930_pre.xml EX-101.PRE 264343
10 EXTRACTED XBRL INSTANCE DOCUMENT syn-20210930x10q_htm.xml XML 863842
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 211376355
SIC: 2834 Pharmaceutical Preparations